Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05379712 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nutritional Supplementation in Head and Neck Cancers

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Oct 2025 to Oct 2026
    • Start date changed from estimate of Jul 2024 to Oct 25, 2024
    • Site details revised
    v5
  2. Notable Primary and study completion dates: Oct 2024 to Oct 2025
    • Start date: Sep 2023 to Jul 2024
    v4
  3. Notable Primary completion date: Oct 2023 to Oct 2024
    • Start date: Jun 2023 to Sep 2023
    • Study completion date: Apr 2024 to Oct 2024
    • Eligibility criteria shortened, about 5 words
    v3
  4. Notable Primary completion date: Mar 2025 to Oct 2023
    • Start date: Dec 2022 to Jun 2023
    • Study completion date: Mar 2025 to Apr 2024
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine whether multimodal nutrition therapy (primary nutrition intervention + adjuvant nutrition therapy) will support patients to optimize their total caloric intake during cancer treatment by measuring the difference in mean cumulative energy intake between the intervention and control group over the duration of cancer treatment.
Trial Details
NCT Number NCT05379712
Lead Sponsor AHS Cancer Control Alberta
Conditions
(from sponsor)
Malnourishment, Nutritional Deficiency, Undernutrition
Related terms Malnutrition
Enrollment 81 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov